Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alka Shaktan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
F1000Research|January 19, 2026
Influencer Marketing in Rural Tourism: Enhancing Destination Image and Encouraging Homestay ChoicesRohit Chauhan, Alka Shaktan, Ankit Shukla, et al.
Journal of Psychoactive Drugs|June 15, 2023
Effectiveness of buprenorphine (naloxone) for opioid dependence does not differ across opioid categories: a retrospective cohort study from IndiaAbhishek Ghosh, Alka Shaktan, Debasish Basu, et al.
Psychopharmacology|February 13, 2023
Heroin use and neuropsychological impairments: comparison of intravenous and inhalational useAbhishek Ghosh, Alka Shaktan, Ritu Nehra, et al.
Journal of Psychoactive Drugs|January 22, 2024
Neurocognitive Dysfunctions in People with Concurrent Cannabis Use and Opioid Dependence: A Cross-Sectional, Controlled StudyAbhishek Ghosh, Alka Shaktan, Abhishek Verma, et al.
Journal of Clinical Psychopharmacology|February 29, 2024
Neurocognitive Functions After 6-Month Buprenorphine (Naloxone)-Based Opioid Agonist Maintenance Treatment: A Controlled Prospective StudyAbhishek Ghosh, Alka Shaktan, Ritu Nehra, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
F1000Research|January 19, 2026
Influencer Marketing in Rural Tourism: Enhancing Destination Image and Encouraging Homestay ChoicesRohit Chauhan, Alka Shaktan, Ankit Shukla, et al.
Journal of Psychoactive Drugs|June 15, 2023
Effectiveness of buprenorphine (naloxone) for opioid dependence does not differ across opioid categories: a retrospective cohort study from IndiaAbhishek Ghosh, Alka Shaktan, Debasish Basu, et al.
Psychopharmacology|February 13, 2023
Heroin use and neuropsychological impairments: comparison of intravenous and inhalational useAbhishek Ghosh, Alka Shaktan, Ritu Nehra, et al.
Journal of Psychoactive Drugs|January 22, 2024
Neurocognitive Dysfunctions in People with Concurrent Cannabis Use and Opioid Dependence: A Cross-Sectional, Controlled StudyAbhishek Ghosh, Alka Shaktan, Abhishek Verma, et al.
Journal of Clinical Psychopharmacology|February 29, 2024
Neurocognitive Functions After 6-Month Buprenorphine (Naloxone)-Based Opioid Agonist Maintenance Treatment: A Controlled Prospective StudyAbhishek Ghosh, Alka Shaktan, Ritu Nehra, et al.
Pageof 1